Aakash Desai, Assistant Professor at O’Neal Comprehensive Cancer Center at UAB, shared on LinkedIn:
“T-2 ASCO24 set to showcase some Small Cell Lung Cancer (SCLC) research, hopefully pushing boundaries in this field!
Improving outcomes for SCLC is a critical need!
Current management algorithm for SCLC, with addition of Tarlatamab in 2024!
And some interesting studies being presented at ASCO24, with the ADRIATIC in plenary- will it change SOC??”
Source: Aakash Desai/LinkedIn